Media Summary: In this webinar, Sreehari Babu, Sr. Vice President — Formulations Solutions at Aragen Life Sciences, deep dives into how ... Drug molecules with poor water solubility or limited bioavailability present significant clinical challenges. One solution is to ... Could there be a new way to improve the solubility of poorly soluble APIs? Our newly launched microparticle technology ...
Amorphous Solid Dispersion Development For - Detailed Analysis & Overview
In this webinar, Sreehari Babu, Sr. Vice President — Formulations Solutions at Aragen Life Sciences, deep dives into how ... Drug molecules with poor water solubility or limited bioavailability present significant clinical challenges. One solution is to ... Could there be a new way to improve the solubility of poorly soluble APIs? Our newly launched microparticle technology ... For more information, visit www.austinpx.com/kinetisol The KinetiSol™ Technology generates Amorphous Solid Dispersion Development for For Dr. Frank Romanski, it is important to understand that
Dr. Frank Romanski speaks about the the role of excipient selection and key characteristics in See the KinetiSol Compounder in action and learn how AustinPx's proprietary KinetiSol™ Technology supports I caught up with Philippe to find out more about his upcoming presentation at DDF Summit North America next week about ASD ... Watch this webinar to understand how integrated formulation and PK solutions can accelerate the
